Stem Cell Therapy Pioneer, Dr. Amit Patel, Treats More Heart Failure Patients in Bangkok
Posted May 22 2010 12:00am
As clinical trials in America are barely getting started; already the good results supports the use of stem cells for heart treatment. Read this article which popped up in my search today for “stem cell improvement” stories…and make sure you read the last paragraph for the surprise ending! – dg
One of the world’s leading physicians in adult stem cell therapy for heart disease, Dr. Amit Patel M.D., returned to Thailand this week to oversee the treatment of three more American heart failure patients and one Australian patient by leading Thai thoracic surgeons and cardiologists.
Dr. Patel decided to continue treating patients suffering from non-ischemic cardiomyopathy in Thailand after MRI testing confirmed the improvement of his first patient, Jeannine Lewis, three months after she received stem cell therapy there.
Ms. Lewis was a no-option patient who was unable to qualify for any clinical trials.
She was in Class III-IV heart failure (the borderline of needing a heart transplant) and on maximal oral medical therapy.
Her preoperative echocardiogram showed an Ejection Fraction (EF) of 25-30%.
At three months, her EF had improved to 41% and she was reclassified in only Class I (the mildest form) heart failure.
Her shortening fraction (a slightly different way of measuring left ventricle performance than ejection fraction-dg) and stroke volume had also increased.
“I am encouraged by our initial success in Thailand and I am looking forward to returning here to treat more patients in the near future,” said Dr. Patel.
Recently, Dr. Patel, who is the Director of Cardiac Stem Cell Therapies at The McGowan Institute for Regenerative Medicine, University of Pittsburgh Medical Center (UPMC), received approval from the US FDA to initiate clinical trials using adult stem cells derived from bone marrow to treat heart patients at UPMC.
In Thailand, Dr. Patel is using VesCell™ adult stem cell technology from TheraVitae® in conjunction with the minimally invasive thoracoscopic injection procedure that he pioneered. VesCell employs adult stem cells harvested from a small amount of the patient’s own blood and does not require bone marrow extraction.
Currently, two leading hospitals in Bangkok are using VesCell adult stem cells to treat patients who are suffering from heart disease. Bangkok Heart Hospital is focusing on the treatment of non-ischemic cardiomyopathy and Chaophya Hospital is concentrating its efforts on ischemic heart disease (coronary artery disease).
Impressive, right? Cutting edge, right? You’re glad the stem cell results are finally bearing fruit, right? Guess again. This article, which came up in today’s google search, is actually from October of 2005! To date Dr Patel and VesCell have treated hundreds of patients with a very impressive track record of improvements and results! If only the US would catch up… -dg